Company intelligence / Profile preview

Aadi Bioscience, Inc.

Morristown, New Jersey, United Statesaadibio.com ↗

Ownership: Public · AADI
Employees: ~40
Development stage: NDA

Overview

Aadi Bioscience developed and commercialized FYARRO® (albumin-bound sirolimus), FDA-approved for advanced PEComa. In March–April 2025 the company rebranded to Whitehawk Therapeutics after pivoting away from its commercial business due to a failed Phase II trial in solid tumors. The company now focuses on preclinical development of three newly licensed antibody-drug conjugate programs targeting various cancers. The proceeds from selling its legacy business are expected to fund operations through at least the end of 2028.[4][7]

Therapeutic areas: Oncology
Modalities: Antibody-drug conjugates (ADCs) [current focus][7][8]Albumin-bound nanoparticle sirolimus ("nab-sirolimus") [legacy asset][4][6]
Industry: Biotech

Drug pipeline

2 assets

nab-sirolimus

Approved

1 more asset in the full pipeline.

Request access →

Partnerships

WuXi Biologics and Hangzhou DAC — licensing partners for all three current ADC assets.[7]

Financials

Market cap: $94.9M
Total revenue: $0
Enterprise value: $-95.1M

Beyond the preview

Go deeper on Aadi Bioscience, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aadi Bioscience, Inc..

Explore the full profile